Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Kwon

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Blood Neoplasia|January 15, 2026
Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomasJulio C Chavez, Ellen Napier, Attilio Bondanza, et al.
Cancer Research|January 28, 2004
Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824Peter Atadja, Lin Gao, Paul Kwon, et al.
Nature|January 17, 2020
Design and synthesis of multigrain nanocrystals via geometric misfit strainMyoung Hwan Oh, Min Gee Cho, Dong Young Chung, et al.
The Lancet. Gastroenterology & Hepatology|December 5, 2024
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trialSéverine Vermeire, Stefan Schreiber, David T Rubin, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
De novo design of metal-oxide templating proteinsAmijai Saragovi, Harley Pyles, Timothy F Huddy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2018
Preclinical Antitumor Activity of a Novel Anti-c-KIT Antibody-Drug Conjugate against Mutant and Wild-type c-KIT-Positive Solid TumorsTinya Abrams, Anu Connor, Christie Fanton, et al.
Journal of Medicinal Chemistry|October 3, 2003
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)Stacy W Remiszewski, Lidia C Sambucetti, Kenneth W Bair, et al.
Molecular Cancer Therapeutics|April 21, 2021
PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing MalignanciesQing Sheng, Joseph A D'Alessio, Daniel L Menezes, et al.
Journal of Medicinal Chemistry|June 10, 2011
Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitorsMichael D Shultz, Xueying Cao, Christine H Chen, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Blood Neoplasia|January 15, 2026
Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomasJulio C Chavez, Ellen Napier, Attilio Bondanza, et al.
Cancer Research|January 28, 2004
Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824Peter Atadja, Lin Gao, Paul Kwon, et al.
Nature|January 17, 2020
Design and synthesis of multigrain nanocrystals via geometric misfit strainMyoung Hwan Oh, Min Gee Cho, Dong Young Chung, et al.
The Lancet. Gastroenterology & Hepatology|December 5, 2024
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trialSéverine Vermeire, Stefan Schreiber, David T Rubin, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
De novo design of metal-oxide templating proteinsAmijai Saragovi, Harley Pyles, Timothy F Huddy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2018
Preclinical Antitumor Activity of a Novel Anti-c-KIT Antibody-Drug Conjugate against Mutant and Wild-type c-KIT-Positive Solid TumorsTinya Abrams, Anu Connor, Christie Fanton, et al.
Journal of Medicinal Chemistry|October 3, 2003
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)Stacy W Remiszewski, Lidia C Sambucetti, Kenneth W Bair, et al.
Molecular Cancer Therapeutics|April 21, 2021
PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing MalignanciesQing Sheng, Joseph A D'Alessio, Daniel L Menezes, et al.
Journal of Medicinal Chemistry|June 10, 2011
Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitorsMichael D Shultz, Xueying Cao, Christine H Chen, et al.
Pageof 4